Status:
NOT_YET_RECRUITING
Effects of Monitoring Blood Pressure During Pregnancy
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
Birth Weight
Weight Gain Trajectory
Eligibility:
FEMALE
18-60 years
Phase:
NA
Brief Summary
In this study, at least 400 women with high-risk of pregnancy hypertension will use a wearable device to monitor the blood pressure during gestational age from 12 weeks to 28weeks. The observed outcom...
Eligibility Criteria
Inclusion
- Women with a single pregnancy before 12 weeks of pregnancy
- The presence of any of the following risk factors: age \> 30 years, a history of eclampsia, a family history of eclampsia, obesity (BMI ≥ 30 Kg/m2), and a history of gestational hyperglycemia (pregestational type 1 and type 2 diabetes; gestational manifest diabetes and gestational diabetes requiring insulin treatment), preexisting chronic hypertension, kidney disease, and autoimmune diseases such as systemic lupus erythematosus and antiphospholipid syndrome.
- Signed the informed consent can be continuously followed up.
- Permanent population living in the study area.
- All subjects received routine antenatal examination and treatment.
Exclusion
- Termination of pregnancy before 20 weeks
- Withdraw from the study
- Lost visitors
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06217913
Start Date
December 1 2024
End Date
June 30 2027
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China, 200092